| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |